AI assistant
Sending…
Aurinia Pharmaceuticals Inc. — Director's Dealing 2021
Jun 17, 2021
31941_dirs_2021-06-17_4587df8c-8afe-4da3-aad2-b7d6e4f55248.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: Aurinia Pharmaceuticals Inc. (AUPH)
CIK: 0001600620
Period of Report: 2021-06-14
Reporting Person: Balakrishnan Brinda (Director)
More from Aurinia Pharmaceuticals Inc.
Regulatory Filings
2026
May 11
Interim / Quarterly Report
2026
May 7
Regulatory Filings
2026
May 7
Regulatory Filings
2026
Apr 3
Regulatory Filings
2026
Mar 23
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3